Citius pharmaceuticals announces closing of $20.0 million private placement offering priced at-the-market

Cranford, n.j., jan. 27, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has closed on the sale to certain...
CTXR Ratings Summary
CTXR Quant Ranking